The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphoma

出版年份 2008 全文链接

标题

作者

关键词

出版物

Volume 142, Issue 1, Pages 65-68

出版商

Wiley

发表日期

2008-05-09

DOI

10.1111/j.1365-2141.2008.07145.x

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now